Loading clinical trials...
Loading clinical trials...
The purpose of this protocol is to collect serum zonulin levels in people with schizophrenia. This one time visit will collect zonulin levels, antibodies to gliadin (tissue transglutaminase and antigliadin antibodies) and other information that may relate to increased intracellular tight junction permeability as it related to the immune and stress system and the immune association with kynurenic acid pathway 50. Data will be collected for use in future grant applications and published reports.
Age
18 - 75 years
Sex
ALL
Healthy Volunteers
No
Maryland Psychiatric Research Center
Catonsville, Maryland, United States
Start Date
July 1, 2011
Primary Completion Date
February 1, 2012
Completion Date
February 1, 2012
Last Updated
September 26, 2019
100
ACTUAL participants
Blood Draw
PROCEDURE
Lead Sponsor
University of Maryland, Baltimore
Collaborators
NCT07239336
NCT07455929
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06356220